Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Aug 20 424B3 Prospectus supplement
- 21 Aug 20 EFFECT Notice of effectiveness
- 19 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
12 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Jul 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Jun 20 S-4 Registration of securities issued in business combination transactions
ACET similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
resTORbio, Inc.:
We consent to the use of our report dated March 12, 2020, with respect to the consolidated balance sheets of resTORbio, Inc. as of December 31, 2019 and 2018, the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and stockholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
August 11, 2020